Earnings NewsHealthcareGemphire Therapeutics EPS misses by $0.08Aug. 09, 2019 8:06 AM ETGemphire Therapeutics Inc. (GEMP) StockGEMPBy: Niloofer Shaikh, SA News Editor Gemphire Therapeutics (NASDAQ:GEMP): Q2 GAAP EPS of -$0.20 misses by $0.08. Cash and cash equivalents of $3.64M Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgGEMP--Gemphire Therapeutics Inc.Trending AnalysisTrending News